Modified IL-4 mutein receptor antagonists

Details for Australian Patent Application No. 2004270638 (hide)

International Classifications

Event Publications

13 April 2006 PCT application entered the National Phase

PCT publication WO2005/023860 Priority application(s): WO2005/023860

29 June 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 May 2006

31 January 2008 Amendment Made

The nature of the amendment is: Delete priority details 60/528,228 US 8 Apr 2004 2005

31 January 2008 Assignment before Grant

Bayer Pharmaceuticals Corporation The application has been assigned to Aerovance, Inc.

7 October 2010 Application Accepted

Published as AU-B-2004270638

3 February 2011 Standard Patent Sealed

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.